This is not the most recent version of the article. View current version (20 AUG 2016)

Intervention Protocol

You have free access to this content

Smoking cessation in smokers with chronic obstructive pulmonary disease

  1. Eva van Eerd1,*,
  2. Regina M van der Meer2,
  3. Ayalu A Reda3,
  4. Constant Paul van Schayck4,
  5. Daniel Kotz5

Editorial Group: Cochrane Airways Group

Published Online: 17 SEP 2013

DOI: 10.1002/14651858.CD010744


How to Cite

van Eerd E, van der Meer RM, Reda AA, van Schayck CP, Kotz D. Smoking cessation in smokers with chronic obstructive pulmonary disease (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 9. Art. No.: CD010744. DOI: 10.1002/14651858.CD010744.

Author Information

  1. 1

    Maastricht University Medical Centre, CAPHRI School for Public Health and Primary Care, Department of Family Medicine, Maastricht, Netherlands

  2. 2

    STIVORO, Dutch Expert Centre on Tobacco Control, The Hague, Netherlands

  3. 3

    Brown University, Population Studies and Training Center, Providence, RI, USA

  4. 4

    CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Department of General Practice, Maastricht, Netherlands

  5. 5

    Maastricht University Medical Centre, Department of General Practice, CAPHRI School for Public Health and Primary Care, Maastricht, Netherlands

*Eva van Eerd, Department of Family Medicine, Maastricht University Medical Centre, CAPHRI School for Public Health and Primary Care, Maastricht, Netherlands. eva.vaneerd@maastrichtuniversity.nl.

Publication History

  1. Publication Status: New
  2. Published Online: 17 SEP 2013

SEARCH

This is not the most recent version of the article. View current version (20 AUG 2016)

References

Additional references

Anthonisen 2002
  • Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of lung health study participants after 11 years. American Journal of Respiratory and Critical Care Medicine 2002;166:675-9.
Borrelli 2010
Buist 2007
  • Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet 2007; Vol. 370, issue 9589:741-50.
Cahill 2012
Celli 2004
Geijer 2005
  • Geijer RM, Sachs AP, Hoes AW, Salome PL, Lammers JW, Verheij TJ. Prevalence of undetected persistent airflow obstruction in male smokers 40-65 years old. Family Practice 2005;22(5):485-9.
GOLD 2013
  • Global strategy for the diagnosis, management, and prevention of COPD. http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html. Global Initiative for Chronic Obstructive Lung Disease (GOLD), (accessed 27 May 2013).
Hajek 2013
  • Hajek P, McRobbie H, Myers K. Efficacy of cytisine in helping smokers quit: systematic review and meta-analysis. Thorax 2013 Feb 12 [Epub ahead of print]. [DOI: 10.1136/thoraxjnl-2012-203035]
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Chichester: John Wiley & Sons, 2008.
Hilberink 2011
  • Hilberink SR, Jacobs JE, van Opstal S, van der Weijden T, Keegstra J, Kempers PLJ, et al. Validation of smoking cessation self-reported by patients with chronic obstructive pulmonary disease. International Journal of General Medicine 2011;4:85-90.
Hughes 2003
Hughes 2012
Jimenez-Ruiz 2001
  • Jimenez-Ruiz CA, Masa F, Miravitlles M, Gabriel R, Viejo JL, Villasante C, et al. Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest 2001;119(5):1365-70.
Kerstjens 1997
Kohansal 2009
  • Kohansal R, Martinez-Camblor P, Agusti A, Buist AS, Mannino DM, Soriano JB. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. American Journal of Respiratory and Critical Care Medicine 2009;180(1):3-10.
Liberati 2009
  • Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of Clinical Epidemiology 2009;62(10):e1-34.
Mannino 2007
NICE 2010
  • NICE. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adult in primary and secondary care (CG101). www.guidance.nice.org.uk/CG101. London: National Clinical Guideline Centre, (accessed 20 June 2013).
Qaseem 2011
  • Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Annals of Internal Medicine 2011;155(3):179-91.
Shahab 2006
  • Shahab L, Jarvis MJ, Britton J, West R. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax 2006;61(12):1043-7.
Stead 2012
Strassmann 2009
  • Strassmann R, Bausch B, Spaar A, Kleijnen J, Braendli O, Puhan MA. Smoking cessation interventions in COPD: a network meta-analysis of randomised trials. The European Respiratory Journal 2009;34(3):634-40.
Tobacco Use and Dependence Guideline Panel 2008
  • Treating tobacco use and dependence: 2008 update. www.ncbi.nlm.nih.gov/books/NBK63950/. Rockville, MD: U.S.: Department of Health and Human Services. Public Health Service, (accessed 5 December 2012).
Tonnesen 2007
  • Tonnesen P, Carrozzi L, Fagerstrom KO, Gratziou C, Jimenez-Ruiz C, Nardini S, et al. Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. The European Respiratory Journal 2007;29(2):390-417.
Tzanakis 2004
van der Meer 2001
  • van der Meer RM, Wagena EJ, Ostelo RW, Jacobs JE, van Schayck CP. Smoking cessation for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2001, Issue 1. [DOI: 10.1002/14651858.CD002999]
Wagena 2005
  • Wagena EJ, Knipschild PG, Huibers MJ, Wouters EF, van Schayck CP. Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. Archives of Internal Medicine 2005;165(19):2286-92.
West 2005
Willemse 2004
  • Willemse BW, Postma DS, Timens W, ten Hacken NH. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. European Respiratory Journal 2004;23(3):464-76.
Wilson 2011
  • Wilson JS, Elborn JS, Fitzsimons D, McCrum-Gardner E, et al. Do smokers with chronic obstructive pulmonary disease report their smoking status reliably? A comparison of self-report and bio-chemical validation. International Journal of Nursing Studies 2011;48(7):856-62.